Mechanism of Action of PARP Inhibitors. Note: in the presence of a PARP... | Download Scientific Diagram
Activity Goals. Perspectives on PARP Inhibitors in Ovarian Cancer Has the Time Come for Individualized Care? - ppt download
PARP inhibitor combination therapy. | Semantic Scholar
JCM | Free Full-Text | PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers | HTML
PARP Inhibitors Are Improving the Outlook of Hard-to-Treat Cancers | The Scientist Magazine®
Advances in the Treatment of Ovarian Cancer Using PARP Inhibitors and the Underlying Mechanism of Resistance | Bentham Science
PARP inhibitors in cancer treatment | OncologyPRO
PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review)
An Overview of PARP Inhibitors for the Treatment of Breast Cancer | SpringerLink
Dual mechanism of action of PARPi. Notes: Olaparib inhibits parylation... | Download Scientific Diagram
Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance | Experimental & Molecular Medicine
Effects of pharmacologic PARP inhibition in B16F10 melanoma cells.... | Download Scientific Diagram
PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review)
An update on PARP inhibitors—moving to the adjuvant setting | Nature Reviews Clinical Oncology
PARP inhibitors: Synthetic lethality in the clinic
An In-Depth Review of Niraparib in Ovarian Cancer: Mechanism of Action, Clinical Efficacy and Future Directions | SpringerLink
PARP inhibitors: Treating mCRPC from a genetic basis
Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
PARP Inhibitors: Where Are We in 2020 and What's Coming Next?
Use of PARP inhibitors in ovarian cancer | Cancer World Archive
Cancers | Free Full-Text | PARP Inhibitors in Melanoma—An Expanding Therapeutic Option? | HTML
An Overview of PARP Inhibitors for the Treatment of Breast Cancer | SpringerLink
